Catalog Products » CD84/SLAMF5, His & Avi, Human
Manual
Manual
COAs

CD84/SLAMF5, His & Avi, Human

Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of CD5 B lymphocytes in peripheral blood, lymphoid organs and bone marrow. The main feature of the disease is accumulation of the malignant cells due to decreased apoptosis. CD84 belongs to the signaling lymphocyte activating molecule family of immunoreceptors, and has an unknown function in CLL cells.
$250.00
Z04231-100

Ask us a question
Product Introduction
Species Human
Protein Construction
CD84/SLAMF5 (Lys22-Gly225)
Accession # Q9UIB8-1		 His Avi
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 25.4 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 40-55 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.
Back

CD84/SLAMF5, His & Avi, Human

The purity of CD84/SLAMF5, His & Avi, Human is greater than 95% as determined by SEC-HPLC. »

CD84/SLAMF5, His & Avi, Human

CD84/SLAMF5, His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »

<
>

Background
Target Background Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of CD5 B lymphocytes in peripheral blood, lymphoid organs and bone marrow. The main feature of the disease is accumulation of the malignant cells due to decreased apoptosis. CD84 belongs to the signaling lymphocyte activating molecule family of immunoreceptors, and has an unknown function in CLL cells.
Synonyms Hly9-beta; CD84; SLAMF5; LY9B; CD84 molecule; DKFZp781E2378;Hly9-β
Back

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.